Loading...
Phase I study of panobinostat (LBH589) and letrozole in post-menopausal metastatic breast cancer patients
INTRODUCTION/BACKGROUND: Histone deacetylase inhibitors have been found to restore sensitivity to the estrogen receptor in endocrine resistant and triple negative breast cancer cell lines. We decided to test panobinostat, a pan histone deacetylase inhibitor, based on preclinical data in combination...
Na minha lista:
| Udgivet i: | Clin Breast Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5567753/ https://ncbi.nlm.nih.gov/pubmed/26774555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2015.11.003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|